Tuberous Sclerosis treatment

Details for Australian Patent Application No. 2011205053 (hide)

Owner Novartis AG

Inventors Lebwohl, David; Lane, Heidi; Elmroth, Ingrid; Sellers, William; Stumm, Michael; Berg, William; Benedetto, John

Agent Davies Collison Cave

Pub. Number AU-A-2011205053

Parent 2007211613

Filing date 28 July 2011

Wipo publication date 25 August 2011

International Classifications

A61K 31/436 (2006.01)

A61K 31/351 (2006.01) - not condensed with another ring

A61K 31/365 (2006.01) - Lactones

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

11 August 2011 Complete Application Filed

25 August 2011 Application Open to Public Inspection

  Published as AU-A-2011205053

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011205054-Flexible display translation

2011205052-Buses